No Data
No Data
Barclays Maintains Overweight on Intellia Therapeutics, Lowers Price Target to $55
Adaptive Biotechnologies Corporation (ADPT) Q3 2024 Earnings Call Transcript Summary
Intellia Therapeutics, Inc. (NTLA) Q3 2024 Earnings Call Transcript Summary
A Closer Look at 4 Analyst Recommendations For Recursion Pharmaceuticals
Here Are the Major Earnings After the Close Today
Where Ionis Pharmaceuticals Stands With Analysts
103721817 : stock exchange
Boganji4 : hello
103698043 : Bought some TMF last month, started to gain